Federal Trade Commission

Products in a loading bay at an Amazon fulfillment center on Prime Day in Melville, New York, US, on Tuesday, July 11, 2023. Amazon.com Inc.'s annual Prime Day shows that e-commerce isn't the driver it once was for the stock, as investor…

Robert Galbraith | ReutersThe Federal Trade Commission last week allowed Amgen to move forward with its $27.8 billion acquisition of Horizon Therapeutics under a settlement agreement –  a move that could have ramifications for a string of…

Representative Image (Photo: Bloomberg) The US Federal Trade Commission (FTC) is finalising its long-awaited antitrust lawsuit against Amazon in a move that could ultimately break up parts of the company, Politico reported on…

Rafael Henrique | Lightrocket | Getty ImagesEuropean Union regulators on Wednesday fined Illumina a record 432 million euros ($476 million) for closing its acquisition of cancer test developer Grail without first securing regulatory…

In a blog post, Microsoft corporate vice president for Xbox Dave McCarthy outlined additional steps the company is now taking to improve its age verification systems and to ensure that parents are involved in the creation of child accounts…

In a blog post, Microsoft corporate vice president for Xbox Dave McCarthy outlined additional steps the company is now taking to improve its age verification systems and to ensure that parents are involved in the creation of child accounts…

Robert Galbraith | ReutersHorizon Therapeutics expects its $27.8 billion sale to Amgen to close as early as the end of the third quarter, earlier than previously planned — if the Federal Trade Commission's attempt to block the deal fails —…

Robert Galbraith | ReutersHorizon Therapeutics' stock plunged more than 17% in premarket trading Tuesday after a report that the Federal Trade Commission is preparing to file a lawsuit to block the biotech company's $27.8 billion sale to…

Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016.David A. Grogan | CNBCCarl Icahn on Friday called Illumina's first-quarter results "very disappointing" and slammed the DNA sequencing company's new plans to cut costs. …

…